Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2005-08-30
2005-08-30
Switzer, Juliet C. (Department: 1634)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S006120
Reexamination Certificate
active
06936442
ABSTRACT:
Human parvovirus B19 primers and probes derived from conserved regions of the parvovirus B19 genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes.
REFERENCES:
patent: 5283174 (1994-02-01), Nelson et al.
patent: 5399491 (1995-03-01), Kacian et al.
patent: 5516630 (1996-05-01), Ticehurst et al.
patent: 5538848 (1996-07-01), Livak et al.
patent: 5723591 (1998-03-01), Livak et al.
patent: 5876930 (1999-03-01), Livak et al.
patent: 6154707 (2000-11-01), Livak et al.
patent: 6183999 (2001-02-01), Weimer et al.
patent: 6204044 (2001-03-01), Brown
patent: 6238860 (2001-05-01), Whelihan
patent: 6287815 (2001-09-01), Brown
patent: 6294338 (2001-09-01), Nunomura
patent: 6642033 (2003-11-01), Lazo et al.
patent: 0 514 413 (1994-05-01), None
patent: 0 491 824 (1995-05-01), None
patent: 0 690 990 (1998-11-01), None
patent: 06293798 (1994-10-01), None
patent: 09010000 (1997-01-01), None
patent: 11225797 (1999-08-01), None
patent: WO 91/12269 (1991-08-01), None
patent: WO 94/10294 (1994-05-01), None
patent: WO 96/09391 (1996-03-01), None
patent: WO 97/21346 (1997-06-01), None
patent: WO 99/18227 (1999-04-01), None
patent: WO 01/06019 (2001-01-01), None
Shade et al. (GenBank Accession M12178 (GI: 333375), Human parvovirus B19-Au DNA, partial genome).
Bassam et al. (Australasian Biotechnology, vol. 6, No. 5, Oct. 1996, pp. 285-294).
Aberham et al. (Journal of Virological Methods 92(2001)183-191).
Ticehurst, et al., “Hepatitis A Virus (HAV) Peptide Corresponding to the Capsid Protein Region of Poliovirus RNA.” Database Geneseq, accession No: AAP50287 sequence alignment with instant SEQ ID NO: 1, Nov. 30, 1991 (Abstract).
Bostic et al., “Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay,”J. Inf. Dis.179:619-626, 1999.
Calvet et al., “Parvovirus B19 infection in thoracic organ transplant recipients,”J. Clin. Virol.13:37-42, 1999.
Cassinotti et al., “Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay,”J. Med. Virol.40:228-234, 1993.
Clewlhy, “Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens,”J. Clin. Microbiol.27:2647-2651, 1989.
Cubie et al., “Synthetic oligonucleotide cocktails as probes for detection of human parvovirus B19,”J. Vir. Meth. 53:91-102, 1995.
Durigon et al., “Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA,”J. Vir. Meth. 44:155-165, 1993.
Fini, “Development of a chemiluminescence competitive PCR for the detection and quantification of parvovirus B19 DNA using a microplate luminometer,”Clin. Chem. 45:1391-1396, 1999.
Fukada et al. “Four putative subtypes of human parvovirus B19 based on amino acid polymorphism in the C-terminal region of non-structural protein,”J. Med Virol. 62:60-69, 2000.
Gallinella et al., “Efficient parvovirus B19 DNA purification and molecular cloning,”J. Virol. Meth. 41:203-211, 1993.
Gruber et al., “Precise quantitation of human parvovirus B19 DNA in biological samples by PCR,”Biologicals26:213-216, 1998.
Hicks et al., “A simple and sensitive DNA hybridization assay used for the routine diagnosis of human parvovirus B19 infection,”J. Clin. Microbiol. 33:2473-2475, 1995.
Holland et al., “Detection of specific polymerase chain reaction product by utilizing the 5′ —>3′ exonuclease activity ofThermus aquaticusDNA polymerase,”PNAS88:7276-7280, 1991.
Koch et al., “Detection of human parvovirus B19 DNA by using the polymerase chain reaction,”J. Clin. Microbiol. 28:65-69, 1990.
Mcomish et al., “Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction,”J. Clin. Microbiol. 31:323-328, 1993.
Nelson, “Molecular tools for building nucleic acid IVDS,”IVDT archive, Mar. 1998 http://devicelink.com/ivdt/archive/98/03/013.html
Patou et al., “Characterization of a nested polymerase chain reaction assay for detoction of parvovirus B19,”J. Clin. Microbiol. 31:540-546, 1993.
Searle et al., “Acute parvovirus B19 infection in pregnant women—an analysis of serial samples by serological and semi-quantitative PCR techniques,”Infection26:139-143, 1998.
Shade et al., “Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis,”J. Virol. 58:921-936, 1986.
Sisk et al., “Expression of human parvovirus B19 structural protein inE. coliand detection of antiviral antibodies in human serum,”Biotechnology5:1077-1080, 1987.
Takahashi et al., “Genetic heterogeneity of the immunogenic viral capsid protein region of human parvovirus B19 isolates obtained from an outbreak in a pediatric ward,”FEBS Lett. 450:289-293, 1999.
Pichuantes Sergio
Shyamala Venkatakrishna
Chiron Corporation
Harbin Alisa A.
Lillis Marcella
Robins Roberta L.
Switzer Juliet C.
LandOfFree
Diagnostic assays for parvovirus B19 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic assays for parvovirus B19, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic assays for parvovirus B19 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3500803